The downregulation of Bcl-xL has been shown to induce apoptosis and increase chemosensitivity[1,2] but resistance to chemotherapy is still observed in some cancer cells even after Bcl-2/Bcl-xL inhibition[3,4]. This evidence concerns the gene BCL2 and cancer.